Cardiac autophagic vacuolation in severe X-linked myopathy with excessive autophagy

Neuromuscul Disord. 2017 Feb;27(2):185-187. doi: 10.1016/j.nmd.2016.10.007. Epub 2016 Oct 19.

Abstract

X-linked myopathy with excessive autophagy (XMEA), caused by mutations of the VMA21 gene, is a strictly skeletal muscle disease. Extensive studies in yeast established VMA21 as the master assembly chaperone of V-ATPase, the complex multisubunit proton pump that acidifies organelles and that is vital to all mammalian tissues. As such, skeletal muscle disease exclusivity in XMEA is highly surprising. We now show that the severest VMA21 mutation, c.164-6t>g, does result in XMEA-typical pathology with autophagic vacuolar changes outside skeletal muscle, namely in the heart. However, even patients with this mutation do not exhibit clinical extramuscular disease, including cardiac disease, despite extreme skeletal muscle wasting to the extent of ventilation dependence. Uncovering the unique skeletal muscle vulnerability to defective organellar acidification, and resultant tissue-destructive excessive autophagy, will be informative to the understanding of muscle physiology. Alternatively, understanding extramuscular resistance to VMA21 mutation might disclose heretofore unknown mammalian V-ATPase assembly chaperones other than VMA21.

Keywords: Acidification; Autophagy; CAVM; Congenital; LAMP2; Lysosome; XMEA.

Publication types

  • Case Reports

MeSH terms

  • Autophagy
  • Child, Preschool
  • Fatal Outcome
  • Genetic Diseases, X-Linked / genetics
  • Genetic Diseases, X-Linked / pathology*
  • Humans
  • Male
  • Muscular Diseases / genetics
  • Muscular Diseases / pathology*
  • Myocardium / pathology*
  • Vacuolar Proton-Translocating ATPases / genetics*
  • Vacuoles / pathology*

Substances

  • VMA21 protein, human
  • Vacuolar Proton-Translocating ATPases

Supplementary concepts

  • Myopathy, X-Linked, with Excessive Autophagy